Diabetes and antenatal milk expressing (DAME) : a randomised controlled trial.

Not Applicable

Completed

• Conditions: Lactation; eonatal admission to Special and Intensive care, ,; Neonatal/infant feeding; Hypoglycaemia; Pregnancy outcomes; Maternal diabetes,; Neonatal admission to Special and Intensive care, ,; Reproductive Health and Childbirth - Complications of newborn; Reproductive Health and Childbirth - Childbirth and postnatal care; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12611000217909
• Lead Sponsor: Judith Lumley Centre, La Trobe University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-02-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 658

Inclusion Criteria

Any woman with pre-existing or gestational diabetes; between 34 and 36 weeks gestation; with a singleton pregnancy in a cephalic presentation; attending the study sites for pregnancy care as a public patient; planning to breastfeed and able to speak , read and write in English

Exclusion Criteria

Women -any history of antepartum haemorrhage, or placenta praevia -an unknown or classical caesarean section scar or more than one lower uterine segment caesarean section scar -any suspicion of fetal compromise - a known fetal abnormality.

Study & Design

• Study Type: Interventional
• Study Design: Not specified